{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:31:45Z","timestamp":1785897105681,"version":"3.56.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"29","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2021,9,17]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The MAO enzyme is presented in the brain and peripheral tissues\nand is a significant enzyme that is responsible for the deamination of biogenic\namines and thus the regulation of neurotransmitter levels. The reaction of these neurotransmitters\nwith the MAO enzyme produces aldehyde and free amine. MAO enzyme\nconsists of two isoforms, MAO-A and MAO-B, which are characterized by amino acid\nsequence, three-dimensional structure, substrate preference, and inhibitor selectivity. Dopamine,\ntyramine, and tryptamine are substrates of both MAO isoforms and MAO inhibitors\nsuch as clorgiline and selegiline, which are used as medications in neurodegenerative\nand neurological diseases. In particular, MAO-A inhibitors are used in the treatment\nof depression, while MAO-B inhibitors are used in the treatment of Parkinson's disease.\nIt is also investigated whether MAO-B inhibitors are effective in the treatment of\nAlzheimer's disease. Nowadays, life expectancy has increased, as a result, neurodegenerative\ndiseases such as Parkinson's and Alzheimer's disease have started to occur more frequently.\nThe elderly population is increasing day by day. As a result of these common\ndiseases in elderly people, these people are unable to do their jobs and need care. Therefore,\nthese diseases have become a significant health problem in society.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In this study, review, inclusion, and exclusion criteria were used. Peer-reviewed\nresearch articles were searched. The quality of the examined articles was evaluated\nwith standard tools. The information obtained was analyzed conceptually by using\nqualitative content analysis methodology.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>One hundred and five papers were included in the review. The current MAO-B\ninhibitors and their usage areas are discussed together with the structures of the drugs; also,\ntheir possible effects in Alzheimer\u2019s and Parkinson\u2019s treatment are evaluated. In addition,\ndifferent articles have been compiled in which structures such as arylalkylamines,\nchalcones, benzoquinone, benzoxazinone, and chromen are substituted with various functional\ngroups and aromatic rings, along with thestructures of 44 different compounds that\nhave recently been developed and their inhibitory effects on MAO-B enzyme. As a result,\nthe structure required for MAO-B inhibition and SAR studies is discussed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> Many studies demonstrate that MAO-B activity increases with age in brain\ntissue, cerebrospinal fluid (CSF), and platelets in Alzheimer's patients. This suggests that\nMAO-B inhibitor drugs, which may be effective in the treatment of Parkinson's disease,\nmay also be effective in the treatment of Alzheimer's disease. This article was written to\nexplain the multifaceted MAO-B inhibitor molecules.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867328666210203204710","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T16:46:21Z","timestamp":1612457181000},"page":"6045-6065","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Monoamine Oxidase-B (MAO-B) Inhibitors in the Treatment of Alzheimer\u2019s and Parkinson\u2019s Disease"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4559-2305","authenticated-orcid":true,"given":"Zeynep","family":"\u00d6zdemir","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Inonu University, Malatya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5190-7196","authenticated-orcid":true,"given":"Mehmet Abdullah","family":"Alag\u00f6z","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Inonu University, Malatya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4045-4555","authenticated-orcid":true,"given":"\u00d6mer Faruk","family":"Bah\u00e7ecio\u011flu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Inonu University, Malatya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3179-1899","authenticated-orcid":true,"given":"Selim","family":"G\u00f6k","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Inonu University, Malatya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/191113","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/191113\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/191113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T13:53:30Z","timestamp":1632491610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/191113\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":0,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2021,9,17]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867328666210203204710","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}